ProQR Therapeutics N.V.

NASDAQ:PRQR

Biotechnology

Healthcare
$1.10 +12.28%

+$0.21 today

Market cap
$155.23M
Beta
0.06
P/E (TTM)
-3.8
EPS (TTM)
-$0.43
52W Low $1.33High $3.10

Volume 0.88M

Average 0.62M

Income Statement

Follow revenue through to earnings.

Revenue

$15.28M

FY 2025 · Annual

-19.2% YoY

Operating Income

-$42.15M

FY 2025 · Annual

Net Income

-$40.52M

FY 2025 · Annual

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.34M3.59M6.51M18.91M15.28M
Cost of Revenue00002.6M
Gross Profit1.34M3.59M6.51M18.91M12.68M
Gross Margin100.0%100.0%100.0%100.0%83.0%
Research & Development42.22M50.87M25.15M36.36M40.72M
Selling, General & Admin17.37M18.65M16.24M13.66M14.12M
Operating Expenses58.55M68.75M38.37M49.38M54.84M
Depreciation & Amortization2.33M2.52M2.51M2.76M2.6M
EBITDA(54.95M)(56.46M)(24.1M)(24.12M)(37.04M)
EBITDA Margin-4116.0%-1571.0%-369.9%-127.6%-242.4%
Operating Income(57.21M)(65.16M)(31.86M)(30.47M)(42.15M)
Operating Margin-4285.4%-1813.0%-489.1%-161.2%-275.9%
Interest Income5K106K2.59M3.25M2.24M
Interest Expense3.41M5.13M1.2M1.08M866.4K
Other Income / Expenses(3.47M)1.05M4.05M2.51M1.65M
Income Before Tax(60.68M)(64.11M)(27.81M)(27.96M)(40.5M)
Pre-Tax Margin-4545.5%-1783.8%-427.0%-147.9%-265.1%
Income Tax Expense117K96K(78K)(197K)18.25K
Net Income(60.74M)(64.42M)(28.12M)(27.76M)(40.52M)
Net Margin-4549.8%-1792.5%-431.7%-146.9%-265.2%
EPS (Basic)(0.96)(0.91)(0.35)(0.34)(0.38)
EPS (Diluted)(0.96)(0.91)(0.35)(0.34)(0.38)
Weighted Avg Shares64.18M71.64M81.01M81.67M105.33M
Weighted Avg Shares (Diluted)64.18M71.64M81.01M81.67M105.33M

PRQR Earnings Waterfall · TTM

NASDAQ:PRQR · Revenue to Net Income

Key Ratios

EPS$-0.44
Gross Margin87.8%
Net Margin-386.3%
P/E Ratio-4.0
P/S Ratio55.7

Analysis

$13.4M of revenue converted into -$45.6M of net income for the selected period. Gross margin is 87.8% and net margin is -386.3%, showing how much revenue survives after costs and taxes. EPS is $-0.44, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
6-K6-K filingNov 12, 2026
6-K/A6-K/A filingOct 30, 2026
6-K6-K filingOct 28, 2026
6-K6-K filingSep 23, 2026

How much revenue does PRQR generate?

ProQR Therapeutics N.V. (PRQR) reported $15.28M of revenue in fiscal 2025.

Is PRQR profitable?

ProQR Therapeutics N.V. (PRQR) reported -$40.52M of net income, with a net margin of -265.2%.